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Abstract 
Background: Herpes simplex virus type 2 (HSV-2) is a common sexually transmitted 
infection with more than 500 million individuals infected world-wide. A major global health 
problem is that HSV-2 infection facilitates the spread of HIV. This epidemiological situation 
warrants the development of a vaccine to reduce the spread of HSV-2. As HSV-2 often is 
transmitted without symptoms type specific serology is valuable in diagnosis of the infection. 
The envelope glycoprotein G (gG-2) of HSV-2 is cleaved intracellularly into a membrane 
bound portion (mgG-2) and a secreted portion (sgG-2). Although the function of mgG-2 is 
unknown the protein induces a type specific antibody response. This feature is utilized in 
several serological HSV-2 type specific assays. A general problem is that assays which are 
reliable in Western world country populations show lower performance for sera from African 
countries.  
Aims: To evaluate sgG-2 as type specific antigen in ELISA for detection of HSV-2 infection 
in a Swedish cohort and define the performance for both sgG-2 and mgG-2 in ELISA for high 
HSV-2 prevalence cohorts in Tanzania (paper I and II). To elucidate the function of mgG-2, 
using HSV-2 mutants, in a genital mouse model (paper III) and to evaluate mgG-2 as a 
vaccine candidate against genital HSV-2 infection in mice (paper IV). 
Methods: Natively produced sgG-2 and mgG-2 proteins were purified by immunosorbent 
columns from HSV-2 infected cell cultures. For the vaccine studies mgG-2 was purified using 
Helix pomatia lectin affinity chromatography. A frame shift HSV-2 mutant devoid of mgG-2 
and an emerald green fluorescent protein labelled sgG-2 and mgG-2 negative HSV-2 were 
used for functional studies in C57BL/6 mice. Viral load was estimated by virus isolation and 
by real time PCR. C57BL/6 mice were immunized with mgG-2 and CpG as adjuvant and 
challenged genitally with wild type HSV-2.  
Results: We showed that sgG-2 is a novel antigen that can be used for type specific 
serological diagnosis of HSV-2 infection and that an ELISA based on mgG-2 can improve the 
detection of HSV-2 infected individuals from Africa. Both mgG-2 deficient HSV-2 mutants 
were severely attenuated and all mice survived a genital infection. The viral mutants infected 
the genital mucosa but did not induce genital disease and were not propagated to the sensory 
ganglia or to the CNS. Finally, mice immunized with mgG-2 and adjuvant were highly 
protected against a lethal dose of wild type HSV-2. Protection was associated with an 
enhanced Th1 response and IFN-γ production in re-stimulated CD4+ T cells.  
Conclusion: Native sgG-2 and mgG-2 proteins induce type specific antibody responses and 
perform well in ELISA in low as well as in high HSV-2 prevalence populations. The mgG-2 
protein has an important function in the ability of HSV-2 to infect nervous tissue. As 
vaccination with mgG-2 protects mice from lethal disease mgG-2 constitutes a promising 
vaccine candidate against HSV-2 infection. In human trials detection of anti-sgG-2 antibodies 
may be a valuable tool to discriminate between vaccine induced immunity and natural HSV-2 
infections.  
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